ATE426018T1
(de)
|
1997-04-10 |
2009-04-15 |
Stichting Katholieke Univ |
Pca3, pca3-gene und verfahren zu ihrer verwendung
|
PT1086223E
(pt)
|
1998-06-01 |
2009-11-03 |
Agensys Inc |
Novos antigénios transmembranares em serpentina expressos em cancros humanos e suas utilizações
|
US6833438B1
(en)
|
1999-06-01 |
2004-12-21 |
Agensys, Inc. |
Serpentine transmembrane antigens expressed in human cancers and uses thereof
|
US20030149531A1
(en)
|
2000-12-06 |
2003-08-07 |
Hubert Rene S. |
Serpentine transmembrane antigens expressed in human cancers and uses thereof
|
US7037667B1
(en)
|
1998-06-01 |
2006-05-02 |
Agensys, Inc. |
Tumor antigen useful in diagnosis and therapy of prostate and colon cancer
|
US7368545B1
(en)
|
1999-09-29 |
2008-05-06 |
Diagnocure Inc. |
PCA3 messenger RNA species in benign and malignant prostate tissues
|
US7361338B2
(en)
|
1999-10-05 |
2008-04-22 |
Agensys, Inc. |
Methods to inhibit growth of prostate cancer cells
|
US6790631B1
(en)
|
1999-10-05 |
2004-09-14 |
Agensys, Inc. |
G protein-coupled receptor up-regulated in prostate cancer and uses thereof
|
US20020048777A1
(en)
|
1999-12-06 |
2002-04-25 |
Shujath Ali |
Method of diagnosing monitoring, staging, imaging and treating prostate cancer
|
US20090176722A9
(en)
|
2000-01-28 |
2009-07-09 |
Shiv Srivastava |
Androgen-regulated PMEPA1 gene and polypeptides
|
JP2004505617A
(ja)
|
2000-07-28 |
2004-02-26 |
ヴィッセンバッハ,ウルリヒ |
Trp8、Trp9およびTrp10、癌の新規マーカー
|
WO2002040716A2
(en)
|
2000-11-16 |
2002-05-23 |
Cemines, Llc |
Profiling tumor specific markers for the diagnosis and treatment of neoplastic disease
|
US7459539B2
(en)
|
2000-12-15 |
2008-12-02 |
Agensys, Inc. |
Antibody that binds zinc transporter protein 108P5H8
|
AU2002249816A1
(en)
*
|
2000-12-15 |
2002-07-24 |
Millennium Pharmaceuticals, Inc. |
Human sugar transporter proteins, potassium channel proteins, phospholipid transporter proteins and methods of use thereof
|
US7118912B2
(en)
*
|
2002-08-26 |
2006-10-10 |
Case Western Reserve University |
Methods and compositions for categorizing patients
|
US7081516B2
(en)
|
2002-08-26 |
2006-07-25 |
Case Western Reserve University |
Methods for categorizing patients
|
US20060035237A1
(en)
|
2002-08-26 |
2006-02-16 |
Markowitz Sanford D |
Methods and compositions for categorizing patients
|
CA2439702A1
(en)
*
|
2001-03-05 |
2002-09-19 |
Aventis Pharma S.A. |
Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof
|
US7736654B2
(en)
|
2001-04-10 |
2010-06-15 |
Agensys, Inc. |
Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
|
US6897024B2
(en)
|
2001-05-31 |
2005-05-24 |
Stichting Katholieke Universiteit More Particularly The University Medical Centre Nijmegen |
Nucleic acid molecules comprising the promoter for PCA3, and uses thereof
|
KR100607612B1
(ko)
*
|
2001-06-20 |
2006-08-02 |
제넨테크, 인크. |
종양의 진단 및 치료를 위한 방법 및 이를 위한 조성물
|
US20050272120A1
(en)
|
2001-06-20 |
2005-12-08 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
IL160651A0
(en)
|
2001-08-31 |
2004-07-25 |
Agensys Inc |
Nucleic acid and correspondidng protein entitled 205pib5 and pharmaceutical compositions containing the same
|
ES2532757T3
(es)
|
2001-09-06 |
2015-03-31 |
Agensys, Inc. |
Ácido nucleico y proteína correspondiente denominados STEAP-1 útiles en el tratamiento y la detección de cáncer
|
US7494646B2
(en)
|
2001-09-06 |
2009-02-24 |
Agensys, Inc. |
Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
|
AU2002367585A1
(en)
*
|
2001-09-17 |
2003-09-22 |
Millennium Pharmaceuticals, Inc. |
Methods of using 46828, a human acyl-coa synthetase
|
US20030100034A1
(en)
*
|
2001-10-16 |
2003-05-29 |
Millennium Pharmaceuticals, Inc. |
9136, a human aldehyde dehydrogenase family member and uses therefor
|
CA2470088A1
(en)
*
|
2001-12-20 |
2003-07-03 |
Tularik Inc. |
Identification of an amplified gene and target for drug intervention
|
WO2003070889A2
(en)
*
|
2002-02-19 |
2003-08-28 |
Idec Pharmaceuticals Corporation |
Prostate specific genes and the use thereof in design or therapeutics
|
WO2005067629A2
(en)
*
|
2004-01-06 |
2005-07-28 |
Avalon Pharmaceuticals |
Cancer-linked genes as targets for chemotherapy
|
US20040162236A1
(en)
*
|
2002-04-01 |
2004-08-19 |
John Alsobrook |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
EP1361433A3
(en)
*
|
2002-04-09 |
2005-02-23 |
Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo |
Method for estimating therapeutic efficacy of tumor necrosis factor (TNF)
|
ATE440613T1
(de)
*
|
2002-05-10 |
2009-09-15 |
Jackson H M Found Military Med |
Androgen-reguliertes pmepa1 gen und verfahren zu seiner verwendung zur hemmung von krebszellwachstum
|
DE10234901A1
(de)
*
|
2002-07-26 |
2004-02-12 |
Metagen Pharmaceuticals Gmbh |
Verwendung von am Mrp4 bindenden Substanzen zur Diagnose und Behandlung von Krebserkrankungen
|
WO2004015108A1
(en)
*
|
2002-08-09 |
2004-02-19 |
Melbourne Health |
Mammalian grainyhead transcription factors
|
AU2003243151A1
(en)
|
2002-08-16 |
2004-03-03 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
|
EP1575993A4
(en)
*
|
2002-08-26 |
2007-07-25 |
Univ Case Western Reserve |
METHODS OF PATIENT TREATMENT AND THERAPEUTIC IDENTIFICATION
|
AU2003283427A1
(en)
*
|
2002-12-09 |
2004-06-30 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with phosphodiesterase 9a1 (pde9a1)
|
ES2427853T3
(es)
|
2003-02-07 |
2013-11-04 |
Diagnocure Inc. |
Procedimiento para detectar cáncer de próstata en una muestra
|
JP2004357702A
(ja)
*
|
2003-05-09 |
2004-12-24 |
Research Association For Biotechnology |
新規蛋白質およびそれをコードするdna
|
US7473531B1
(en)
|
2003-08-08 |
2009-01-06 |
Colora Corporation |
Pancreatic cancer targets and uses thereof
|
US7294704B2
(en)
|
2003-08-15 |
2007-11-13 |
Diadexus, Inc. |
Pro108 antibody compositions and methods of use and use of Pro108 to assess cancer risk
|
KR101520209B1
(ko)
|
2003-11-06 |
2015-05-13 |
시애틀 지네틱스, 인크. |
리간드에 접합될 수 있는 모노메틸발린 화합물
|
EP1730279A2
(en)
*
|
2004-02-27 |
2006-12-13 |
Oncotherapy Science, Inc. |
Epha4 as therapeutic target of prc and pdaca
|
AU2004319915B9
(en)
|
2004-04-22 |
2011-12-22 |
Agensys, Inc. |
Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
|
WO2005106488A2
(en)
*
|
2004-04-28 |
2005-11-10 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with g protein-coupled beta-2 adrenoceptor (adrb2)
|
BRPI0510883B8
(pt)
|
2004-06-01 |
2021-05-25 |
Genentech Inc |
composto conjugado de droga e anticorpo, composição farmacêutica, método de fabricação de composto conjugado de droga e anticorpo e usos de uma formulação, de um conjugado de droga e anticorpo e um agente quimioterapêutico e de uma combinação
|
WO2006008003A2
(en)
*
|
2004-07-23 |
2006-01-26 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with vasoactive intestinal peptide receptor 1 (vpac1)
|
ES2579805T3
(es)
|
2004-09-23 |
2016-08-16 |
Genentech, Inc. |
Anticuerpos y conjugados modificados por ingeniería genética con cisteína
|
US20100111856A1
(en)
|
2004-09-23 |
2010-05-06 |
Herman Gill |
Zirconium-radiolabeled, cysteine engineered antibody conjugates
|
JP4993645B2
(ja)
|
2004-12-01 |
2012-08-08 |
ジェネンテック, インコーポレイテッド |
抗体薬剤結合体および方法
|
CA2491067A1
(en)
|
2004-12-24 |
2006-06-24 |
Stichting Katholieke Universiteit |
Mrna rations in urinary sediments and/or urine as a prognostic marker for prostate cancer
|
WO2006074914A2
(en)
*
|
2005-01-13 |
2006-07-20 |
Novartis Forschungsstiftung, Zweigniederlassung Friedrich Miescher Institute For Biomedical Research |
Human rna helicase and therapeutic uses thereof
|
DK2325306T3
(en)
*
|
2005-02-25 |
2014-03-03 |
Oncotherapy Science Inc |
Peptide vaccines against lung cancers expressing TTK, URLC10 or KOC1 polypeptide
|
ES2636089T3
(es)
|
2006-10-27 |
2017-10-05 |
Genentech, Inc. |
Anticuerpos e inmunoconjugados y usos para los mismos
|
US9551033B2
(en)
|
2007-06-08 |
2017-01-24 |
Genentech, Inc. |
Gene expression markers of tumor resistance to HER2 inhibitor treatment
|
DK2171090T3
(da)
*
|
2007-06-08 |
2013-06-10 |
Genentech Inc |
Genekspressionsmarkører for tumorresistens over for HER2-inhibitorbehandling
|
CA2736170A1
(en)
|
2007-09-06 |
2009-03-12 |
Case Western Reserve University |
Methods for diagnosing and treating cancers
|
JP5589274B2
(ja)
*
|
2007-10-25 |
2014-09-17 |
東レ株式会社 |
免疫誘導剤
|
KR101633351B1
(ko)
*
|
2007-10-25 |
2016-06-27 |
도레이 카부시키가이샤 |
암의 검출 방법
|
AU2014240339B2
(en)
*
|
2007-10-25 |
2017-07-13 |
Toray Industries, Inc. |
Method for detection of cancer
|
AU2009270988A1
(en)
|
2008-07-15 |
2010-01-21 |
Genentech, Inc. |
Anthracycline derivative conjugates, process for their preparation and their use as antitumor compounds
|
TW201008574A
(en)
|
2008-08-19 |
2010-03-01 |
Oncotherapy Science Inc |
INHBB epitope peptides and vaccines containing the same
|
TWI543767B
(zh)
|
2008-08-19 |
2016-08-01 |
腫瘤療法 科學股份有限公司 |
Hig2與urlc10抗原決定位胜肽以及含此胜肽之疫苗
|
CA2809819A1
(en)
|
2009-09-09 |
2011-03-17 |
Centrose, Llc |
Extracellular targeted drug conjugates
|
ES2430567T3
(es)
|
2010-04-15 |
2013-11-21 |
Spirogen Sàrl |
Pirrolobenzodiacepinas y conjugados de las mismas
|
MA34291B1
(fr)
*
|
2010-05-03 |
2013-06-01 |
Genentech Inc |
Compositions et méthodes de diagnostic et de traitement d'une tumeur
|
EP2579897A1
(en)
|
2010-06-08 |
2013-04-17 |
Genentech, Inc. |
Cysteine engineered antibodies and conjugates
|
JP5889912B2
(ja)
|
2010-11-17 |
2016-03-22 |
ジェネンテック, インコーポレイテッド |
アラニニルメイタンシノール抗体コンジュゲート
|
US8679767B2
(en)
|
2011-05-12 |
2014-03-25 |
Genentech, Inc. |
Multiple reaction monitoring LC-MS/MS method to detect therapeutic antibodies in animal samples using framework signature peptides
|
PT2750713E
(pt)
|
2011-10-14 |
2016-01-20 |
Genentech Inc |
Pirrolobenzodiazepinas e conjugados das mesmas
|
WO2013130093A1
(en)
|
2012-03-02 |
2013-09-06 |
Genentech, Inc. |
Biomarkers for treatment with anti-tubulin chemotherapeutic compounds
|
SI2906253T1
(sl)
|
2012-10-12 |
2018-11-30 |
Adc Therapeutics Sa |
Konjugati pirolobenzodiazepin-protitelo proti PSMA
|
AU2013328623B8
(en)
|
2012-10-12 |
2017-06-15 |
Adc Therapeutics Sa |
Pyrrolobenzodiazepine-antibody conjugates
|
ES2649990T3
(es)
|
2012-10-12 |
2018-01-16 |
Medimmune Limited |
Conjugados de anticuerpos anti-CD22-pirrolobenzodiazepinas
|
NZ707543A
(en)
|
2012-10-12 |
2018-09-28 |
Adc Therapeutics Sa |
Pyrrolobenzodiazepine-antibody conjugates
|
ES2680153T3
(es)
|
2012-10-12 |
2018-09-04 |
Adc Therapeutics Sa |
Conjugados de anticuerpos anti-PSMA-pirrolobenzodiazepinas
|
ES2530968T3
(es)
|
2012-10-12 |
2015-03-09 |
Spirogen Sarl |
Pirrolobenzodiazepinas y conjugados de las mismas
|
US10695433B2
(en)
|
2012-10-12 |
2020-06-30 |
Medimmune Limited |
Pyrrolobenzodiazepine-antibody conjugates
|
CA2894961C
(en)
|
2012-12-21 |
2020-09-15 |
Spirogen Sarl |
Pyrrolobenzodiazepines and conjugates thereof
|
US9567340B2
(en)
|
2012-12-21 |
2017-02-14 |
Medimmune Limited |
Unsymmetrical pyrrolobenzodiazepines-dimers for use in the treatment of proliferative and autoimmune diseases
|
CA2901941C
(en)
|
2013-03-13 |
2020-04-07 |
Spirogen Sarl |
Pyrrolobenzodiazepines and conjugates thereof
|
CN105209077B
(zh)
|
2013-03-13 |
2019-06-11 |
麦迪穆有限责任公司 |
吡咯并苯并二氮杂卓以及其结合物
|
AU2014229529B2
(en)
|
2013-03-13 |
2018-02-15 |
Medimmune Limited |
Pyrrolobenzodiazepines and conjugates thereof
|
WO2014144657A2
(en)
*
|
2013-03-15 |
2014-09-18 |
Metamark Genetics, Inc. |
Compositions and methods for cancer prognosis
|
EP3033111B1
(en)
|
2013-08-12 |
2019-03-13 |
Genentech, Inc. |
1-(chloromethyl)-2,3-dihydro-1h-benzo[e]indole dimer antibody-drug conjugate compounds, and methods of use and treatment
|
WO2015052534A1
(en)
|
2013-10-11 |
2015-04-16 |
Spirogen Sàrl |
Pyrrolobenzodiazepine-antibody conjugates
|
WO2015052535A1
(en)
|
2013-10-11 |
2015-04-16 |
Spirogen Sàrl |
Pyrrolobenzodiazepine-antibody conjugates
|
WO2015052532A1
(en)
|
2013-10-11 |
2015-04-16 |
Spirogen Sàrl |
Pyrrolobenzodiazepine-antibody conjugates
|
GB201317982D0
(en)
|
2013-10-11 |
2013-11-27 |
Spirogen Sarl |
Pyrrolobenzodiazepines and conjugates thereof
|
RU2689388C1
(ru)
|
2013-12-16 |
2019-05-28 |
Дженентек, Инк. |
Пептидомиметические соединения и их конъюгаты антител с лекарственными средствами
|
CN107106700B
(zh)
|
2013-12-16 |
2020-10-30 |
基因泰克公司 |
肽模拟化合物及其抗体-药物缀合物
|
MX2016007578A
(es)
|
2013-12-16 |
2016-10-03 |
Genentech Inc |
Compuestos de conjugado anticuerpo-farmaco dimerico de 1-(clorometil)-2,3-dihidro-1h-benzo [e] indol, y metodos de uso y tratamiento.
|
US20150252425A1
(en)
*
|
2014-03-05 |
2015-09-10 |
Caldera Health Ltd. |
Gene expression profiling for the diagnosis of prostate cancer
|
CN106687141A
(zh)
|
2014-09-10 |
2017-05-17 |
麦迪穆有限责任公司 |
吡咯并苯并二氮杂卓及其缀合物
|
AR101844A1
(es)
|
2014-09-12 |
2017-01-18 |
Genentech Inc |
Anticuerpos y conjugados modificados genéticamente con cisteína
|
CN106714844B
(zh)
|
2014-09-12 |
2022-08-05 |
基因泰克公司 |
蒽环类二硫化物中间体、抗体-药物缀合物和方法
|
GB201416112D0
(en)
|
2014-09-12 |
2014-10-29 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
EP3194400A1
(en)
|
2014-09-17 |
2017-07-26 |
Genentech, Inc. |
Pyrrolobenzodiazepines and antibody disulfide conjugates thereof
|
CA2968447A1
(en)
|
2014-11-25 |
2016-06-02 |
Adc Therapeutics Sa |
Pyrrolobenzodiazepine-antibody conjugates and their use to treat neoplasms
|
WO2016090050A1
(en)
|
2014-12-03 |
2016-06-09 |
Genentech, Inc. |
Quaternary amine compounds and antibody-drug conjugates thereof
|
GB201506402D0
(en)
|
2015-04-15 |
2015-05-27 |
Berkel Patricius H C Van And Howard Philip W |
Site-specific antibody-drug conjugates
|
GB201506411D0
(en)
|
2015-04-15 |
2015-05-27 |
Bergenbio As |
Humanized anti-axl antibodies
|
GB201510684D0
(en)
*
|
2015-06-17 |
2015-08-05 |
Almac Diagnostics Ltd |
Gene signatures predictive of metastatic disease
|
MA43345A
(fr)
|
2015-10-02 |
2018-08-08 |
Hoffmann La Roche |
Conjugués anticorps-médicaments de pyrrolobenzodiazépine et méthodes d'utilisation
|
MA43354A
(fr)
|
2015-10-16 |
2018-08-22 |
Genentech Inc |
Conjugués médicamenteux à pont disulfure encombré
|
MA45326A
(fr)
|
2015-10-20 |
2018-08-29 |
Genentech Inc |
Conjugués calichéamicine-anticorps-médicament et procédés d'utilisation
|
GB201601431D0
(en)
|
2016-01-26 |
2016-03-09 |
Medimmune Ltd |
Pyrrolobenzodiazepines
|
GB201602356D0
(en)
|
2016-02-10 |
2016-03-23 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
GB201602359D0
(en)
|
2016-02-10 |
2016-03-23 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
EP4273551A3
(en)
|
2016-03-25 |
2024-01-17 |
F. Hoffmann-La Roche AG |
Multiplexed total antibody and antibody-conjugated drug quantification assay
|
GB201607478D0
(en)
|
2016-04-29 |
2016-06-15 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
WO2017201449A1
(en)
|
2016-05-20 |
2017-11-23 |
Genentech, Inc. |
Protac antibody conjugates and methods of use
|
JP7022080B2
(ja)
|
2016-05-27 |
2022-02-17 |
ジェネンテック, インコーポレイテッド |
部位特異的抗体-薬物複合体の特徴付けのための生化学分析的方法
|
JP7043425B2
(ja)
|
2016-06-06 |
2022-03-29 |
ジェネンテック, インコーポレイテッド |
シルベストロール抗体-薬物コンジュゲート及び使用方法
|
JP7093767B2
(ja)
|
2016-08-11 |
2022-06-30 |
ジェネンテック, インコーポレイテッド |
ピロロベンゾジアゼピンプロドラッグ及びその抗体コンジュゲート
|
JP7050770B2
(ja)
|
2016-10-05 |
2022-04-08 |
エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト |
抗体薬物コンジュゲートの調製方法
|
GB201617466D0
(en)
|
2016-10-14 |
2016-11-30 |
Medimmune Ltd |
Pyrrolobenzodiazepine conjugates
|
GB201702031D0
(en)
|
2017-02-08 |
2017-03-22 |
Medlmmune Ltd |
Pyrrolobenzodiazepine-antibody conjugates
|
AU2018217926B2
(en)
|
2017-02-08 |
2019-10-03 |
Adc Therapeutics Sa |
Pyrrolobenzodiazepine-antibody conjugates
|
JP7247101B2
(ja)
|
2017-04-03 |
2023-03-28 |
エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト |
Steap-1に結合する抗体
|
JP2020517609A
(ja)
|
2017-04-18 |
2020-06-18 |
メディミューン リミテッド |
ピロロベンゾジアゼピン複合体
|
EP3612234B1
(en)
|
2017-04-20 |
2024-03-13 |
ADC Therapeutics SA |
Combination therapy with an anti-axl antibody-drug conjugate
|
US11318211B2
(en)
|
2017-06-14 |
2022-05-03 |
Adc Therapeutics Sa |
Dosage regimes for the administration of an anti-CD19 ADC
|
SI3668874T1
(sl)
|
2017-08-18 |
2022-04-29 |
Medimmune Limited |
Pirolobenzodiazepinski konjugati
|
US20200216463A1
(en)
|
2017-09-20 |
2020-07-09 |
Ph Pharma Co., Ltd. |
Thailanstatin analogs
|
GB201803342D0
(en)
|
2018-03-01 |
2018-04-18 |
Medimmune Ltd |
Methods
|
GB201806022D0
(en)
|
2018-04-12 |
2018-05-30 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
WO2020010305A1
(en)
*
|
2018-07-05 |
2020-01-09 |
The Board Of Regents Of The University Of Oklahoma |
Gene signatures for cancer characterization and methods of use
|
GB201814281D0
(en)
|
2018-09-03 |
2018-10-17 |
Femtogenix Ltd |
Cytotoxic agents
|
WO2020086858A1
(en)
|
2018-10-24 |
2020-04-30 |
Genentech, Inc. |
Conjugated chemical inducers of degradation and methods of use
|
GB201818576D0
(en)
*
|
2018-11-14 |
2018-12-26 |
Io Biotech Aps |
Arginase 2 polypeptides
|
CN113227119A
(zh)
|
2018-12-10 |
2021-08-06 |
基因泰克公司 |
用于与含Fc的蛋白质进行位点特异性缀合的光交联肽
|
GB201901197D0
(en)
|
2019-01-29 |
2019-03-20 |
Femtogenix Ltd |
G-A Crosslinking cytotoxic agents
|
GB2597532A
(en)
|
2020-07-28 |
2022-02-02 |
Femtogenix Ltd |
Cytotoxic compounds
|
WO2024138128A2
(en)
|
2022-12-23 |
2024-06-27 |
Genentech, Inc. |
Cereblon degrader conjugates, and uses thereof
|